Browse studies

Find your next paid study

27,292 recruiting studies available now

Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity

The study will assign participants to take either the medication, empagliflozin or a placebo for 12 weeks. The goal of the study is to determine the effects of…

ObesityVascular Health

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06745063

Phase 2

Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Part 3 - Option II

The purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recov…

Traumatic Brain Injury

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT06790095

Phase 3

Pragmatic Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) (AI)

The purpose of this study is to learn whether a computer-based support tool called DEXI (Dermoscopy EXplainable Intelligence) can help dermatologists decide wh…

Malignant Melanoma of SkinOther and Unspecified Malignant Neoplasm of SkinMelanoma in Situ+13 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Observational

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-assoc…

Methamphetamine UseHeart Failure

Estimated

~$10 – $750

Actual pay is set by the research site.

Oregon Health and Science UniversityNCT06461962

Observational

Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring

The TRANSITION-CGM trial will evaluate whether starting continuous glucose monitoring (CGM) before hospital discharge improves blood glucose control in adults …

Type 2 Diabetes

Estimated

~$10 – $675

Actual pay is set by the research site.

University of CincinnatiNCT07890818

Phase 1

A Phase Ib/II, Multi-site, Open-label, Dose Finding Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT326 in Combination With BNT327 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

This is a multi-site, open-label, dose-finding study, consisting of Parts 1, 2a, and 2b to investigate the combination of BNT326 with pumitamig (also known as …

Non-small Cell Lung Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BioNTech SENCT07111520

Phase 2

A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease …

Non-Small Cell Lung Cancerc-MET

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06568939

Health-Related Quality of Life and Clinical Utilization in Pediatric and Young Adult Patients With Hereditary Hemorrhagic Telangiectasia

This observational study evaluates health-related quality of life (HR-QoL) in pediatric and young adult patients aged 2-25 years with Hereditary Hemorrhagic Te…

Hereditary Haemorrhagic Telangiectasia (HHT)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Ashley NelsonNCT07474428

Phase 1

Phase 1, Randomized, Double-blind, Placebo-controlled Trial to Evaluate Safety and Immunogenicity of a Recombinant MVA-BN-EBV Vaccine in Healthy Young Adults From 18 to 30 Years of Age

Phase 1, single-center, randomized, placebo-controlled, double-blind clinical trial. Participants (N = 15) will receive a 2-dose schedule (1 vaccination on da…

Epstein Barr Virus (EBV) Infection

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Bavarian NordicNCT07888088

Observational

Cardiopulmonary, Hemodynamic, And Symptom Responses To Aerobic And Resistance Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia: A Single-center, Single-arm Prospective Clinical Trial.

The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exerc…

Fibromuscular DysplasiaSpontaneous Coronary Artery Dissection

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07526766

Observational

TRiCares Topaz Transcatheter Tricuspid Heart Valve Replacement System IDE Pivotal Study

The purpose of the study is to evaluate safety and effectiveness of the TRiCares Topaz TTVR system for treatment of subjects presenting with clinically relevan…

Tricuspid Regurgitation (TR)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

TRiCaresNCT07528326

Phase 3

A Phase 3, Global, Multi-center, Double-blind, Randomized Study of ASP2138 Plus Chemotherapy (CAPOX or mFOLFOX6) With Pembrolizumab vs Placebo Plus Chemotherapy With or Without Pembrolizumab in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma in Participants Whose Tumors Are HER2-negative and Claudin (CLDN) 18.2-positive

Claudin 18.2 or CLDN18.2 is a protein found on cells in the digestive system. It is also found in some tumors. Researchers are looking at ways to attack CLDN18…

Gastric AdenocarcinomaGastroesophageal Junction (GEJ) Adenocarcinoma

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Astellas Pharma Global Development, Inc.NCT07673887